NO20055836L - Intermediater anvendelige ved syntesen av HIV-proteaseinhibitorer og fremgangsmater for fremstilling av samme - Google Patents

Intermediater anvendelige ved syntesen av HIV-proteaseinhibitorer og fremgangsmater for fremstilling av samme

Info

Publication number
NO20055836L
NO20055836L NO20055836A NO20055836A NO20055836L NO 20055836 L NO20055836 L NO 20055836L NO 20055836 A NO20055836 A NO 20055836A NO 20055836 A NO20055836 A NO 20055836A NO 20055836 L NO20055836 L NO 20055836L
Authority
NO
Norway
Prior art keywords
synthesis
methods
protease inhibitors
hiv protease
producing
Prior art date
Application number
NO20055836A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055836D0 (no
Inventor
Kim Francis Albizati
Srinivasan Babu
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20055836D0 publication Critical patent/NO20055836D0/no
Publication of NO20055836L publication Critical patent/NO20055836L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO20055836A 2003-05-08 2005-12-08 Intermediater anvendelige ved syntesen av HIV-proteaseinhibitorer og fremgangsmater for fremstilling av samme NO20055836L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46923503P 2003-05-08 2003-05-08
PCT/IB2004/001380 WO2004099129A2 (en) 2003-05-08 2004-04-28 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same

Publications (2)

Publication Number Publication Date
NO20055836D0 NO20055836D0 (no) 2005-12-08
NO20055836L true NO20055836L (no) 2006-02-06

Family

ID=33435224

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055836A NO20055836L (no) 2003-05-08 2005-12-08 Intermediater anvendelige ved syntesen av HIV-proteaseinhibitorer og fremgangsmater for fremstilling av samme

Country Status (19)

Country Link
US (1) US7173059B2 (es)
EP (1) EP1633704A2 (es)
JP (1) JP2006525307A (es)
KR (1) KR100695861B1 (es)
CN (1) CN1819993A (es)
AR (1) AR044258A1 (es)
AU (1) AU2004236038A1 (es)
BR (1) BRPI0410125A (es)
CA (1) CA2524927A1 (es)
CL (1) CL2004000960A1 (es)
CO (1) CO5700812A2 (es)
MX (1) MXPA05012036A (es)
NO (1) NO20055836L (es)
NZ (1) NZ543236A (es)
RU (1) RU2321580C2 (es)
SG (4) SG145573A1 (es)
TW (1) TW200505413A (es)
WO (1) WO2004099129A2 (es)
ZA (1) ZA200508711B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG145573A1 (en) * 2003-05-08 2008-09-29 Pfizer Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260461A (en) * 1988-01-11 1993-11-09 Massachusetts Institute Of Technology Ligands for ADH: cinchona alkaloids and moderately sized organic substituents linked through a planar aromatic spacer group
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
ES2233976T3 (es) 1995-09-26 2005-06-16 Japan Tobacco Inc. Procedimiento para producir derivados amidicos e intermedios.
ATE416158T1 (de) * 1995-09-26 2008-12-15 Japan Tobacco Inc Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen
US5587481A (en) * 1996-02-20 1996-12-24 The Monsanto Company Preparation of (S)-decahydroisoquinoline-3-carboxylic acid t-butylamide
US5705647A (en) * 1996-09-05 1998-01-06 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
CN100439331C (zh) * 2002-07-19 2008-12-03 中国科学院上海有机化学研究所 抗爱滋病药物那非那维的中间体、合成方法以及用途
SG145573A1 (en) * 2003-05-08 2008-09-29 Pfizer Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same

Also Published As

Publication number Publication date
BRPI0410125A (pt) 2006-05-09
RU2005135043A (ru) 2006-06-10
SG145574A1 (en) 2008-09-29
WO2004099129A2 (en) 2004-11-18
US7173059B2 (en) 2007-02-06
EP1633704A2 (en) 2006-03-15
NO20055836D0 (no) 2005-12-08
SG145571A1 (en) 2008-09-29
US20050250949A1 (en) 2005-11-10
CA2524927A1 (en) 2004-11-18
CL2004000960A1 (es) 2005-03-18
NZ543236A (en) 2008-06-30
JP2006525307A (ja) 2006-11-09
ZA200508711B (en) 2006-12-27
KR20060009001A (ko) 2006-01-27
CO5700812A2 (es) 2006-11-30
CN1819993A (zh) 2006-08-16
WO2004099129A3 (en) 2005-01-13
AU2004236038A1 (en) 2004-11-18
AR044258A1 (es) 2005-09-07
SG145573A1 (en) 2008-09-29
MXPA05012036A (es) 2006-02-03
RU2321580C2 (ru) 2008-04-10
SG145572A1 (en) 2008-09-29
TW200505413A (en) 2005-02-16
KR100695861B1 (ko) 2007-03-19

Similar Documents

Publication Publication Date Title
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
EA200300017A1 (ru) Ингибиторы серинпротеазы
AU2002320317A1 (en) Novel mesogens and methods for their synthesis and use
EA200600594A1 (ru) Новые гетероциклические соединения - ингибиторы hsp90 и способы их получения
PL372799A1 (en) New compounds
DE60224189D1 (de) Dipeptidylpeptidase-hemmer zur behandlung von diabetes
DK1305286T3 (da) Cyclopentanoindoler, præparater indeholdende sådanne forbindelser og fremgangsmåder til behandling
SE0002102D0 (sv) Chemical compound
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
ATE541857T1 (de) Optimierte fc-varianten und herstellungsverfahren dafür
NO20055741D0 (no) Nye kjemiske forbindelser
NO20033220L (no) Inhibitorer for cruzipain og andre cysteinproteaser
ATE275544T1 (de) Serinprotease-inhibitoren
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
NO20050019L (no) Polytylenglykolaldehyd-derivater
DE60202669D1 (de) 6-phenylbenzonaphthyidine
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
NO20055836L (no) Intermediater anvendelige ved syntesen av HIV-proteaseinhibitorer og fremgangsmater for fremstilling av samme
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
DE60124148D1 (de) Kalzilytische verbindungen
DK1244614T3 (da) Tryptase-inhibitorer
AU2003244235A1 (en) Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for the synthesis thereof and process for preparation of the intermediates
NO20024679D0 (no) Krystallinsk farmasöytikum

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application